PRKAR1A and HLA-A

Number of citations of the paper that reports this interaction (PubMedID 6333425)
7

Data Source:
HPRD (in vitro)

		PRKAR1A	HLA-A
Description		protein kinase cAMP-dependent type I regulatory subunit alpha	major histocompatibility complex, class I, A
Image
GO Annotations	Cellular Component	Immunological Synapse Cytoplasm Multivesicular Body Centrosome Cytosol Axoneme CAMP-dependent Protein Kinase Complex Membrane Nucleotide-activated Protein Kinase Complex Neuromuscular Junction Protein-containing Complex Plasma Membrane Raft Sperm Connecting Piece Ciliary Base Glutamatergic Synapse	Golgi Membrane Endoplasmic Reticulum Endoplasmic Reticulum Membrane Golgi Apparatus Golgi Medial Cisterna Plasma Membrane Integral Component Of Plasma Membrane Cell Surface ER To Golgi Transport Vesicle Membrane Membrane Phagocytic Vesicle Membrane Early Endosome Membrane MHC Class I Protein Complex MHC Class I Peptide Loading Complex Recycling Endosome Membrane Extracellular Exosome Endoplasmic Reticulum Exit Site Integral Component Of Lumenal Side Of Endoplasmic Reticulum Membrane
	Molecular Function	CAMP-dependent Protein Kinase Inhibitor Activity Protein Binding CAMP-dependent Protein Kinase Regulator Activity Protein Domain Specific Binding CAMP Binding Ubiquitin Protein Ligase Binding Protein Kinase A Catalytic Subunit Binding	RNA Binding Signaling Receptor Binding Protein Binding Beta-2-microglobulin Binding Peptide Antigen Binding T Cell Receptor Binding CD8 Receptor Binding TAP Binding TAP Complex Binding
	Biological Process	Mesoderm Formation Regulation Of Transcription By RNA Polymerase II Female Meiotic Nuclear Division Intracellular Signal Transduction Sarcomere Organization Negative Regulation Of Meiotic Nuclear Division Negative Regulation Of Activated T Cell Proliferation Cardiac Muscle Cell Proliferation Negative Regulation Of CAMP-dependent Protein Kinase Activity	T Cell Mediated Cytotoxicity Positive Regulation Of T Cell Mediated Cytotoxicity T Cell Mediated Cytotoxicity Directed Against Tumor Cell Target Antigen Processing And Presentation Of Endogenous Peptide Antigen Via MHC Class I Via ER Pathway, TAP-dependent Antigen Processing And Presentation Of Endogenous Peptide Antigen Via MHC Class I Via ER Pathway, TAP-independent Positive Regulation Of T Cell Cytokine Production Immune Response Detection Of Bacterium Antibacterial Humoral Response Antigen Processing And Presentation Of Endogenous Peptide Antigen Via MHC Class I Positive Regulation Of Interferon-gamma Production CD8-positive, Alpha-beta T Cell Activation Protection From Natural Killer Cell Mediated Cytotoxicity Antigen Processing And Presentation Of Exogenous Peptide Antigen Via MHC Class I Innate Immune Response Defense Response To Gram-positive Bacterium T Cell Receptor Signaling Pathway Positive Regulation Of CD8-positive, Alpha-beta T Cell Proliferation Positive Regulation Of Memory T Cell Activation Positive Regulation Of CD8-positive, Alpha-beta T Cell Activation
Pathways		PKA activation PKA activation in glucagon signalling DARPP-32 events Glucagon-like Peptide-1 (GLP1) regulates insulin secretion Vasopressin regulates renal water homeostasis via Aquaporins CREB1 phosphorylation through the activation of Adenylate Cyclase Hedgehog 'off' state ADORA2B mediated anti-inflammatory cytokines production FCGR3A-mediated IL10 synthesis ALK mutants bind TKIs Signaling by ALK fusions and activated point mutants Factors involved in megakaryocyte development and platelet production	ER-Phagosome pathway ER-Phagosome pathway Endosomal/Vacuolar pathway Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell Interferon gamma signaling E3 ubiquitin ligases ubiquitinate target proteins Interferon alpha/beta signaling Antigen Presentation: Folding, assembly and peptide loading of class I MHC Antigen Presentation: Folding, assembly and peptide loading of class I MHC
Drugs		(Rp)-cAMPS Cyclic GMP Cyclic adenosine monophosphate GEM-231	3-Indolebutyric Acid Nelipepimut-S Nelipepimut-S Coccidioides immitis spherule Coccidioides immitis spherule
Diseases
GWAS		Body size at age 10 ( 32376654) Coronary artery disease ( 33020668) Estimated glomerular filtration rate ( 31152163) Intake of total sugars ( 31005972) Serum alkaline phosphatase levels ( 33547301)	Adult body size ( 32376654) Adverse response to carbamazepine ( 21149285) Apolipoprotein B levels ( 32203549) Autism spectrum disorder or schizophrenia ( 28540026) Beta-2 microglubulin plasma levels ( 23417110) Blood protein levels ( 29875488) Body size at age 10 ( 32376654) C-peptide levels in type I diabetes ( 29404672) Carbamazepine-induced maculopapular exanthema ( 29288229) Carbamazepine-induced reaction with eosinophilia and systemic symptoms ( 31066027) Change in intraocular pressure in response to steroid treatment (triamcinolone acetonide) ( 25813999) Chickenpox ( 28928442) Childhood ear infection ( 28928442) Chronotype ( 30696823) Cold sores ( 28928442) Complement C3 and C4 levels ( 23028341) Crohn's disease ( 22412388) Drug-induced liver injury (amoxicillin-clavulanate) ( 21570397) Drug-induced liver injury (flucloxacillin) ( 30661239) Eosinophil counts ( 32888494) Eosinophil percentage of white cells ( 32888494) Frontal fibrosing alopecia ( 30850646) Hand grip strength ( 29691431) Heel bone mineral density ( 30598549 28869591) Height ( 28552196) Hematocrit ( 27863252) Hemoglobin concentration ( 27863252) Hemoglobin levels ( 32327693) High light scatter reticulocyte count ( 27863252) HIV-1 control ( 20041166) IgA nephropathy ( 32912934 22197929) IgE levels ( 22075330) Immature fraction of reticulocytes ( 32888494) Late-onset myasthenia gravis ( 26562150) Lung adenocarcinoma ( 28604730) Lung cancer in ever smokers ( 28604730) Lymphocyte counts ( 32888494) Mean reticulocyte volume ( 32888494) Menarche (age at onset) ( 25231870) Monocyte percentage of white cells ( 32888494) Mumps ( 28928442) Nasopharyngeal carcinoma ( 19664746 20512145) Plantar warts ( 28928442) Plateletcrit ( 32888494 27863252) Red blood cell count ( 27863252) Reticulocyte count ( 32888494) Setpoint viral load in HIV-1 infection ( 26553974) Shingles ( 28928442) Squamous cell lung carcinoma ( 28604730) Systemic lupus erythematosus ( 26606652 28714469) Type 1 diabetes (age at diagnosis) ( 33179336) Vitiligo ( 20410501 27723757) Waist circumference adjusted for body mass index ( 34021172) Waist-hip index ( 34021172) Waist-to-hip ratio adjusted for BMI ( 34021172) Youthful appearance (self-reported) ( 32339537)
Interacting Genes		47 interacting genes: AKAP1 AKAP10 AKAP11 AKAP4 AKAP5 AKAP7 ARFGEF2 BAHD1 C11orf49 C2orf88 CAPN11 CBS CCNE1 CDK2 CDK4 DTX1 EGFR FAM153B GRB2 HIVEP1 HLA-A ITGA4 MAPK6 MYO7A NELL2 OGT PATZ1 PJA2 PLEKHF2 PRKACA PRKAR1B PRKX PRPF40A PYCARD RAF1 RFC2 RSPH3 SET SETD7 SLC2A4 SMAD2 SPART TAB1 WDCP WNK1 YWHAZ ZBED1	30 interacting genes: APLP2 B2M BCAP31 BUD31 CALR CANX CCR9 CD8A DEK DERL1 ERBB2 GPR35 KIR3DL2 LILRB1 LILRB2 LTB4R2 MAGEA1 MAGEA4 MEOX2 MEX3C PDIA3 PRKAR1A PRKCA SRC STAT3 TAPBP TRA TRB UBB ZDHHC17
Entrez ID		5573	3105
HPRD ID		01786	00826
Ensembl ID		ENSG00000108946	ENSG00000206503
Uniprot IDs		B2R5T5 P10644	B1PKY1 B2R7U3 P04439 Q5SUL5
PDB IDs		5KJX 5KJY 5KJZ	1AKJ 1AO7 1AQD 1B0G 1B0R 1BD2 1DUY 1DUZ 1EEY 1EEZ 1HHG 1HHH 1HHI 1HHJ 1HHK 1HLA 1HSB 1I1F 1I1Y 1I4F 1I7R 1I7T 1I7U 1IM3 1JF1 1JHT 1LP9 1OGA 1P7Q 1Q94 1QEW 1QR1 1QRN 1QSE 1QSF 1QVO 1S8D 1S9W 1S9X 1S9Y 1T1W 1T1X 1T1Y 1T1Z 1T20 1T21 1T22 1TMC 1TVB 1TVH 1UR7 1W72 1X7Q 2AV1 2AV7 2BCK 2BNQ 2BNR 2C7U 2CLR 2F53 2F54 2GIT 2GJ6 2GT9 2GTW 2GTZ 2GUO 2HLA 2HN7 2J8U 2JCC 2P5E 2P5W 2PYE 2UWE 2V2W 2V2X 2VLJ 2VLK 2VLL 2VLR 2X4N 2X4O 2X4P 2X4Q 2X4R 2X4S 2X4T 2X4U 2X70 2XPG 3BGM 3BH8 3BH9 3BHB 3BO8 3D25 3D39 3D3V 3FQN 3FQR 3FQT 3FQU 3FQW 3FQX 3FT2 3FT3 3FT4 3GIV 3GJF 3GSN 3GSO 3GSQ 3GSR 3GSU 3GSV 3GSW 3GSX 3H7B 3H9H 3H9S 3HAE 3HLA 3HPJ 3I6G 3I6K 3I6L 3IXA 3KLA 3MGO 3MGT 3MR9 3MRB 3MRC 3MRD 3MRE 3MRF 3MRG 3MRH 3MRI 3MRJ 3MRK 3MRL 3MRM 3MRN 3MRO 3MRP 3MRQ 3MRR 3MYJ 3NFN 3O3A 3O3B 3O3D 3O3E 3O4L 3PWJ 3PWL 3PWN 3PWP 3QDG 3QDJ 3QDM 3QEQ 3QFD 3QFJ 3QZW 3REW 3RL1 3RL2 3TO2 3UTQ 3UTS 3UTT 3V5D 3V5H 3V5K 3VXM 3VXN 3VXO 3VXP 3VXR 3VXS 3VXU 3W0W 3WL9 3WLB 4E5X 4EMZ 4EN2 4EUP 4F7M 4F7P 4F7T 4FTV 4GKN 4GKS 4HWZ 4HX1 4I48 4I4W 4JFD 4JFE 4JFF 4JFO 4JFP 4JFQ 4K7F 4L29 4L3C 4L3E 4MJ5 4MJ6 4MNQ 4N8V 4NNX 4NNY 4NO0 4NO2 4NO3 4NO5 4NQV 4NQX 4OV5 4QOK 4U6X 4U6Y 4UQ2 4UQ3 4WJ5 4WU5 4WU7 4WUU 5BRZ 5BS0 5C07 5C08 5C09 5C0A 5C0B 5C0C 5C0D 5C0E 5C0F 5C0G 5C0I 5C0J 5D2L 5D2N 5D9S 5DDH 5E00 5E6I 5E9D 5ENW 5EOT 5EU3 5EU4 5EU5 5EU6 5EUO 5F7D 5F9J 5FA3 5FA4 5FDW 5GRD 5GRG 5GSD 5HGA 5HGB 5HGD 5HGH 5HHM 5HHN 5HHO 5HHP 5HHQ 5HYJ 5IRO 5ISZ 5JHD 5JZI 5MEN 5MEO 5MEP 5MEQ 5MER 5N1Y 5N6B 5NHT 5NME 5NMF 5NMG 5NMH 5NMK 5NQK 5SWQ 5TEZ 5W1W 5WJL 5WJN 5WKF 5WKH 5WSH 5WWI 5WWJ 5WWU 5WXC 5WXD 5XOV 5YXN 5YXU 6AM5 6AMT 6AMU 6APN 6AT9 6D78 6D7G 6DKP 6EI2 6ENY 6EQA 6EQB 6EWA 6EWC 6EWO 6G3J 6G3K 6ID4 6J1W 6J29 6J2A 6JOZ 6JP3 6MPP 6NCA 6O9B 6O9C 6OPD 6PBH 6PTB 6PTE 6Q3K 6Q3S 6R2L 6RP9 6RPA 6RPB 6RSY 6SS7 6SS8 6SS9 6SSA
Enriched GO Terms of Interacting Partners?
Tagcloud ?
Tagcloud (Difference) ?
Tagcloud (Intersection) ?